GSK in exclusive discussions with Unilever about Indian Horlicks unit: FT
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
[BENGALURU] GlaxoSmithKline is in exclusive talks to sell its Indian Horlicks nutrition business to Unilever Plc, putting an end to an auction that is expected to fetch more than US$4 billion, Financial Times reported on Tuesday.
GlaxoSmithKline beat a rival bid from Swiss rival Nestle which was also bidding for the unit and looking to expand its portfolio in the powdered hot beverages category, the report added.
In September, sources had told Reuters that Nestle, Unilever and Coca-Cola were among bidders for GSK's Indian Horlicks nutrition business and that Nestle was particularly well-suited to buy the business.
GSK and Unilever did not immediately respond to a request seeking comment outside regular business hours.
REUTERS
Share with us your feedback on BT's products and services
TRENDING NOW
Autobahn Rent A Car directors declared bankrupt over S$50 million each owed to DBS
Amazon’s MGM Studios gains creative control over ‘James Bond’ franchise
UOB’s Wee Ee Cheong says S$4.9 billion Citi deal ‘paying off’ as Asean push accelerates
In taxing wealth, how far can Singapore push property owners?
